BRCA2 and breast cancer: c-Myc directly targets the miR-1245 promoter and enhances its expression, as well as causing downregulation of BRCA2 DNA repair-associated (BRCA2) gene expression and suppressing the ability for homologous recombination in breast cancer cells [88].